The FDA PreCheck Program To Speed-Up US Drug Production
To make the domestic supply chain in the US more robust and self-reliant by way of regulatory predictability, the FDA has announced the FDA PreCheck Program.
US Biotech Companies Need Government Aid to Match with China
As per the CEO of Pfizer, Albert Bourla, US biotech companies need federal support so as to match up with the rapid progression of Chinese biotech firms.
Medicine Manufacturers from Europe Eyeing US Tariff Move
As US President shows more inclination on furthering the tariff rate, medicine manufacturers from Europe are taking steps that would be best suited to them.
Aurobindo acquires Lannett for $250 million as a result of the threat by Trump administration which looms on imposing tariffs on foreign-manufactured drugs.
